Soligenix Inc  

(Public, OTCBB:SNGX)   Watch this stock  
Find more results for OTC:SNGX
-0.13 (-6.91%)
Apr 27 - Close
OTCBB data delayed by 15 mins - Disclaimer
Currency in USD
Range 1.75 - 1.89
52 week 0.91 - 2.30
Open 1.89
Vol / Avg. 55,711.00/87,603.00
Mkt cap 44.04M
P/E     -
Div/yield     -
EPS -0.34
Shares 25.17M
Beta 2.18
Inst. own 17%
Mar 24, 2015
Full Year 2014 Soligenix Inc Earnings Release
Mar 10, 2015
Soligenix Inc at ROTH Conference
Feb 10, 2015
Soligenix Inc at Biotechnology Industry Organization CEO & Investor Conference

Key stats and ratios

Q4 (Dec '14) 2014
Net profit margin 99.81% -95.23%
Operating margin -121.17% -152.79%
EBITD margin - -149.30%
Return on average assets 116.61% -88.14%
Return on average equity - -
Employees 17 -
CDP Score - -


29 Emmons Dr Ste C10
PRINCETON, NJ 08540-5919
United States - Map
+1-609-5388200 (Phone)
+1-609-4526467 (Fax)

Website links


Soligenix, Inc. (Soligenix) is a clinical stage biopharmaceutical company focused on developing products to treat serious inflammatory diseases where there remains an unmet medical need, as well as developing several biodefense vaccines and therapeutics. The BioTherapeutics segment of the Company is developing formulations of oral beclomethasone, while The Vaccines/BioDefense segment of the Company is involved in active development programs for RiVax, the ricin toxin vaccine, VeloThrax, the anthrax vaccine, OrbeShield, the GI acute radiation syndrome (GI ARS) therapeutic and SGX943, the melioidosis therapeutic.

Officers and directors

Christopher J. Schaber Ph.D. Chairman of the Board, President, Chief Executive Officer
Age: 48
Joseph M. Warusz CPA Acting Chief Financial Officer, Vice President - Finance, Corporate Secretary
Age: 58
Oreola Donini Ph.D. Senior Vice President, Chief Scientific Officer
Age: 43
Richard Straube M.D. Senior Vice President and Chief Medical Officer
Age: 63
Marco Maria Brughera Director
Age: 59
Keith L. Brownlie CPA Independent Director
Age: 62
Anthony Gregg Lapointe C.P.A. Independent Director
Age: 56
Robert Joseph Rubin Independent Director
Age: 69
Jerome B. Zeldis M.D., Ph.D. Independent Director
Age: 64